- Home
- Pharmaceuticals
- 040-000-546 4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-Benzenediamine
040-000-546 4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-Benzenediamine
| Type | Active Pharmaceutical ingredient |
| Synonym | 2-(5-Amino-2-methylanilino)-4-(3-pyridyl)pyrimidine;
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine |
| CAS No. | 152460-10-1 |
| Chemical Formula | C16H15N5 |
| Packaging | 1g, 5g, 10g, 25g, 100g, 500g, etc. |
| Form | Yellow solid |
| Assay | ≥98% |
| Related Products | Gefitinib;
4-[(4-Methyl-1-piperazinyl)methyl]benzoic Acid Dihydrochloride; |
- Description
Description
Description
4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-Benzenediamine Introduction
4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-Benzenediamine is an intermediate of imatinib. Imatinib is a first-generation tyrosine kinase inhibitor, a drug for the treatment of chronic myeloid leukemia. It only kills BCR-ABL contained in myeloid cells, preventing cell proliferation and tumor formation, but has no effect on normal cells. It also inhibits PDGF-mediated tumors, including gliomas and prostate cancer.
4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-Benzenediamine Specification
| Melting Point | 133-135℃ |
| Boiling Point | 537.3±60.0℃ |
| Form | Yellow solid |
| Density | 1.266±0.06 g/cm3 |
| Packaging | 1g, 5g, 10g, 25g, 100g, 500g, etc. |
4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-Benzenediamine Applications
4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-Benzenediamine is an intermediate of imatinib.

![4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-Benzenediamine 4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-Benzenediamine](https://www.stanfordchem.com/wp-content/uploads/2022/08/4-methyl-n3-4-3-pyridinyl-2-pyrimidinyl-13-benzenediamine.jpg)





